Equillium, Inc. (EQ) stock
EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.32−0.10 (-7.04%)
Close on Nov 12, 2026Market cap $83.70MP/E –Yield –
Equillium cash
Cash and short-term investments held at the end of each period.
Equillium's cash was $53.32M at Sep 30, 2026. For fiscal 2025 it was $30.28M, up 34.0% from the year before. The highest annual figure on record is $82.20M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.28M | +34.0% |
| FY2024 | Dec 31, 2024 | $22.60M | -44.7% |
| FY2023 | Dec 31, 2023 | $40.90M | -42.4% |
| FY2022 | Dec 31, 2022 | $71.00M | -12.0% |
| FY2021 | Dec 31, 2021 | $80.70M | -1.8% |
| FY2020 | Dec 31, 2020 | $82.20M | +54.8% |
| FY2019 | Dec 31, 2019 | $53.10M | -19.4% |
| FY2018 | Dec 31, 2018 | $65.90M | +827.7% |
| FY2017 | Dec 31, 2017 | $7.10M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $53.32M | +61.0% |
| Q2 FY2026 | Jun 30, 2026 | $57.16M | +397.3% |
| Q1 FY2026 | Mar 31, 2026 | $61.32M | +322.9% |
| Q4 FY2025 | Dec 31, 2025 | $30.28M | +34.0% |
| Q3 FY2025 | Sep 30, 2025 | $33.12M | +27.9% |
| Q2 FY2025 | Jun 30, 2025 | $11.50M | -65.5% |
| Q1 FY2025 | Mar 31, 2025 | $14.50M | -55.1% |
| Q4 FY2024 | Dec 31, 2024 | $22.60M | -44.7% |
| Q3 FY2024 | Sep 30, 2024 | $25.90M | -44.1% |
| Q2 FY2024 | Jun 30, 2024 | $33.30M | -31.2% |
| Q1 FY2024 | Mar 31, 2024 | $32.30M | -47.9% |
| Q4 FY2023 | Dec 31, 2023 | $40.90M | -42.4% |
| Q3 FY2023 | Sep 30, 2023 | $46.30M | +4.0% |
| Q2 FY2023 | Jun 30, 2023 | $48.40M | -16.0% |
| Q1 FY2023 | Mar 31, 2023 | $62.00M | -9.9% |
| Q4 FY2022 | Dec 31, 2022 | $71.00M | -12.0% |
| Q3 FY2022 | Sep 30, 2022 | $44.50M | -50.9% |
| Q2 FY2022 | Jun 30, 2022 | $57.60M | -41.0% |
| Q1 FY2022 | Mar 31, 2022 | $68.80M | -33.9% |
| Q4 FY2021 | Dec 31, 2021 | $80.70M | -1.8% |
| Q3 FY2021 | Sep 30, 2021 | $90.70M | +0.2% |
| Q2 FY2021 | Jun 30, 2021 | $97.60M | +129.1% |
| Q1 FY2021 | Mar 31, 2021 | $104.10M | +118.2% |
| Q4 FY2020 | Dec 31, 2020 | $82.20M | +54.8% |
| Q3 FY2020 | Sep 30, 2020 | $90.50M | +45.5% |
| Q2 FY2020 | Jun 30, 2020 | $42.60M | -25.1% |
| Q1 FY2020 | Mar 31, 2020 | $47.70M | -22.6% |
| Q4 FY2019 | Dec 31, 2019 | $53.10M | -19.4% |
| Q3 FY2019 | Sep 30, 2019 | $62.20M | +1148.4% |
| Q2 FY2019 | Jun 30, 2019 | $56.90M | +701.0% |
| Q1 FY2019 | Mar 31, 2019 | $61.60M | +8307.5% |
| Q4 FY2018 | Dec 31, 2018 | $65.90M | – |
| Q3 FY2018 | Sep 30, 2018 | $4.98M | – |
| Q4 FY2017 | Dec 31, 2017 | $7.10M | – |
| Q3 FY2017 | Sep 30, 2017 | $732.68K | – |
See a number that looks wrong?